China Oncology API Manufacturers Factory Suppliers

We will further enhance the overall competitiveness of the company and strive to become a major supplier of rhIL 11, CAS 145941 26 0, CAS 265121 04 8 at home and abroad.In order to meet market demand and sustainable development, the company has achieved standardized and institutionalized management. We adhere to the business philosophy of "taking the team as the soul, channel as the root, and business-oriented", and are committed to the development and innovation of the Oncology API industry. We sincerely hope to lead the industry in a positive direction and create a more successful and promising future. On the one hand, service commitment can establish the corporate image and improve the popularity of the enterprise. On the other hand, it can become one of the basis for customers to choose the enterprise. We treat our customers wholeheartedly, support our customers, and cooperate with them in strategic cooperation for mutual benefit and win-win. Our corporate culture factors include, performance, efficiency, composure, professionalism and focus. If you are fascinated in our products, make sure you sense absolutely free to go to our web site or make contact with us.

view more

Fosaprepitant Dimeglumine， CAS No.: 265121-04-8，Bulk

Fosaprepitant dimeglumine for injection is a sterile, lyophilized formulation containing fosaprepitant dimeglumine, a prodrug of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist
view more

Daratumumab - Multiple Myeloma (CD-38 Mab), CAS No.: 945721-28-8

As the former gene engineering research center of Huadong Medicine Group, Jiuyuan is the earliest biopharmaceutical company realizing the industrialization of gene engineering in China and is known
view more

Dulaglutide - Diabetes (recombinant Route)， Diabetes Bulk , CAS No.: 923950-08-7

DULAGLUTIDE contains dulaglutide, a human GLP-1 receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1
view more

PegFilgrastim– A Long Lasting RhG-CSF， CAS No.: 208265-92-3，Bulk

Pegfilgrastim (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection
view more

Bone Repair Material With RhBMP-2 - Bone Repair

Indicated in filling and repairing for various reasons caused bone defect, bone non-union, delayed bone healing or unhealing, as well as treated in spinal fusion, joint fusion and orthopedic bone
view more

Daratumumab (with Recombinant Human Hyaluronidase) API, CAS No.: 945721-28-8

Name: Daratumumab (with recombinant human hyaluronidase). CD38 inhibitor with recombinant human hyaluronidase. INDICATIONS: Multiple myeloma
view more

Romosozumab - Osteoporosis, CAS: 909395-70-6

Name: Romosozumab injection . Sclerostin inhibitor. INDICATIONS: Osteoporosis
view more

Recombinant Human Hyaluronidase, CAS:37326-33-3

By breaking down hyaluronic acid in skin tissue, hyaluronic can increase membrane permeability and improve the absorption and dispersion of parenterally administered fluids and drugs into tissue.
view more

Liraglutide (recombinant Route), Diabetes Bulk, CAS No.: 204656-20-2

Liraglutide is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. Liraglutide may be used alone or with other medications.
view more

RhIL-11 (Oprelvekin)– A Drug To Increase Platelet Count, CAS No.: 145941-26-0, Recombinant Human Interleukin-11

Generic Name: Oprelvekin. Chemical Name: Human Interleukin-11 for Injection. The only drug approved by FDA for prevention and treatment of Chemoradiotherapy-induced thrombocytopenia..
view more

Palonosetron Hydrochloride– Anti-emesis After Chemotherapy Or Radiotherapy, CAS No.: 135729-62-3

Generic Name: Palonosetron Hydrochloride injection. The quality and efficacy consistency of generic drugs were evaluated.. The second generation 5-HT3 receptor antagonist, super antagonistic, long -
view more

RhG-CSF (Filgrastim) (Recombinant Human Granulocyte Colony-Stimulating Factor) – A Drug To Increase White Blood Cell Count, CAS No.: 121181-53-1

Generic Name: Filgrastim. Chemical Name: Human Granulocyte-Colony Stimulating Factor (hG-CSF) Injection. The first human granulocyte stimulating factor in China; Approved by German GMP international

Reviews

Related Blog

Richard Beach

Your company has been committed to providing quality products to all partners. We have received the products and believe that they have done it.

Grace Mitchell

Through cooperation, we highly praise this company. This company has first-class team, first-class quality and first-class efficiency. He can perfectly fulfill our needs.

Ruben Brown

This is the first time that our company has purchased products from this company, and it has been received today. The products are of high cost performance and good quality, so I recommend them.

Alma Lowe

After the cooperation, the company still keeps in touch with us to help us solve the questions in the use of the product. At the same time, their technology is constantly being upgraded, and we are

Sherry Redden

Good seller, happy cooperation!

Carl Perry

You were very efficient and prompt in responding to our emails and overall we were very pleased with the cooperation.

The Oncology Market – a CDMO Perspective | CordenPharma...

CordenPharma added significant capacity to its Highly Potent API capabilities with the acquisition of the former Pfizer facility CordenPharma Boulder (CO, US) to address this increased demand in the...

Global Oncology Blockbuster Drugs Market 2022 Industry …...

Jan 04, 2022 · The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025. Download Report Sample: https://dpiresearch....

Oncology API Products - Dr. Reddy's Laboratories...

As one of the largest generic pharmaceutical manufacturers in the world, we have established a niche in generic oncology APIs and partner of choice for supplying APIs to leading oncology...

Oncology Active Pharmaceutical Ingredients (APIs) Market...

The global oncology active pharmaceutical ingredients (APIs) market is expected to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously...

Active Pharmaceutical Ingredients (API) Global Market...

Mar 17, 2021 · Under biotech API and HPAPI, the oncology segmented contributed for the largest share of xx% and xx% in 2020 respectively, and is forecasted to grow at a high single digit CAGR of xx%...

NCI Cancer Clinical Trials Search API - NCI - National Cancer …...

Apr 28, 2022 · This Clinical Trials Search API will enable the community—advocacy groups, academia, and others in the cancer clinical trials ecosystem—to build applications,...

Our company's api domain, dulaglutide injection for weight loss have been continuously improved in variety, output and quality, and are well received by domestic and foreign users. We're well-known as one of the leading Oncology API manufacturers and suppliers in China. We warmly welcome you to wholesale bulk high quality Oncology API at competitive price from our factory. Good service and punctual delivery are available.